Resorbable Vascular Scaffold Market by Material Type, Application, End User

Description

List of Tables

The Resorbable Vascular Scaffold Market was valued at USD 507.12 million in 2023, expected to reach USD 576.57 million in 2024, and is projected to grow at a CAGR of 13.78%, to USD 1,252.52 million by 2030.

Resorbable vascular scaffolds (RVS) are innovative bioresorbable stents used primarily in cardiac interventions to treat coronary artery disease by providing temporary support to the blood vessel. The necessity arises from their potential to reduce complications associated with traditional metal stents, such as late stent thrombosis, while allowing the artery to restore its natural movement and function once the scaffold dissolves. In terms of application, RVS are pivotal in angioplasty procedures, and their end-use scope primarily spans across hospitals, cardiac centers, and ambulatory surgical centers. The market for RVS is driven by the increasing prevalence of cardiovascular disorders, advancements in biodegradable materials, and a growing preference for minimally invasive procedures. However, significant challenges, including high costs, stringent regulatory requirements, and limited long-term clinical data compared to metallic stents, could inhibit growth. Opportunities lie in emerging markets where healthcare infrastructure is rapidly improving, and there's an increasing acceptance of advanced medical technologies. Strategic collaborations with medical research institutions could expedite innovation, particularly in enhancing the efficacy and safety profiles of RVS. Companies should focus on developing scaffolds with improved degradation timelines and enhanced mechanical properties to meet diverse patient needs. Innovation can also be steered towards personalization, producing scaffolds that cater to individual anatomical peculiarities and disease specifics. Market players are advised to invest in comprehensive clinical trials to substantiate long-term safety and effectiveness claims, thereby satisfying both regulatory bodies and healthcare providers. Overall, the RVS market is promising due to its transformative potential in cardiac care; however, it demands meticulous effort in navigation through regulatory landscapes, cost management, and technological enhancements to surmount current limitations and capitalize on burgeoning opportunities.

KEY MARKET STATISTICS
Base Year [2023]	USD 507.12 million
Estimated Year [2024]	USD 576.57 million
Forecast Year [2030]	USD 1,252.52 million
CAGR (%)	13.78%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Resorbable Vascular Scaffold Market

The Resorbable Vascular Scaffold Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

Market Drivers
- Growing Risk of CAD and PAD in the geriatric population
- Number of clinical trials and development in pipeline
- Increasing prevalence of cardiovascular diseases
Market Restraints
- Presence of alternative methods
Market Opportunities
- Growing funding for R&D of surgical procedures
- Inclination towards drug-eluting devices for angioplasty
Market Challenges
- Product recall

Porter's Five Forces: A Strategic Tool for Navigating the Resorbable Vascular Scaffold Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Resorbable Vascular Scaffold Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Resorbable Vascular Scaffold Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Resorbable Vascular Scaffold Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Resorbable Vascular Scaffold Market

A detailed market share analysis in the Resorbable Vascular Scaffold Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Resorbable Vascular Scaffold Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Resorbable Vascular Scaffold Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Resorbable Vascular Scaffold Market

A strategic analysis of the Resorbable Vascular Scaffold Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Resorbable Vascular Scaffold Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, B. Braun Medical Inc., Biotronik SE & Co. KG, Cardionovum GmbH, Elixir Medical Corporation, Kyoto Medical Planning Co., Ltd., Lepu Medical Technology(Beijing)Co.,Ltd., Medtronic PLC, Meril Life Sciences Pvt. Ltd., MicroPort Scientific Corporation, OrbusNeich Medical Company Limited, Reva Medical, Inc., Terumo Corporation, Translumina, and Wego Healthcare (Shenzhen) Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Resorbable Vascular Scaffold Market to forecast the revenues and analyze trends in each of the following sub-markets:

Based on Material Type, market is studied across Metal Based BVS and Polymer Based BVS.
Based on Application, market is studied across Coronary Artery Stents and Peripheral Artery Stents.
Based on End User, market is studied across Ambulatory Surgical Centers, Cardiac Centers, and Hospitals.
Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Product Code: MRR-035AB9C0DAAB

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Growing Risk of CAD and PAD in the geriatric population
  - 5.1.1.2. Number of clinical trials and development in pipeline
  - 5.1.1.3. Increasing prevalence of cardiovascular diseases
- 5.1.2. Restraints
  - 5.1.2.1. Presence of alternative methods
- 5.1.3. Opportunities
  - 5.1.3.1. Growing funding for R&D of surgical procedures
  - 5.1.3.2. Inclination towards drug-eluting devices for angioplasty
- 5.1.4. Challenges
  - 5.1.4.1. Product recall
5.2. Market Segmentation Analysis
5.3. Porter's Five Forces Analysis
- 5.3.1. Threat of New Entrants
- 5.3.2. Threat of Substitutes
- 5.3.3. Bargaining Power of Customers
- 5.3.4. Bargaining Power of Suppliers
- 5.3.5. Industry Rivalry
5.4. PESTLE Analysis
- 5.4.1. Political
- 5.4.2. Economic
- 5.4.3. Social
- 5.4.4. Technological
- 5.4.5. Legal
- 5.4.6. Environmental

6. Resorbable Vascular Scaffold Market, by Material Type

6.1. Introduction
6.2. Metal Based BVS
6.3. Polymer Based BVS

7. Resorbable Vascular Scaffold Market, by Application

7.1. Introduction
7.2. Coronary Artery Stents
7.3. Peripheral Artery Stents

8. Resorbable Vascular Scaffold Market, by End User

8.1. Introduction
8.2. Ambulatory Surgical Centers
8.3. Cardiac Centers
8.4. Hospitals

9. Americas Resorbable Vascular Scaffold Market

9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Resorbable Vascular Scaffold Market

10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Resorbable Vascular Scaffold Market

11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape

12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.4. Strategy Analysis & Recommendation

Companies Mentioned

1. Abbott Laboratories
2. B. Braun Medical Inc.
3. Biotronik SE & Co. KG
4. Cardionovum GmbH
5. Elixir Medical Corporation
6. Kyoto Medical Planning Co., Ltd.
7. Lepu Medical Technology(Beijing)Co.,Ltd.
8. Medtronic PLC
9. Meril Life Sciences Pvt. Ltd.
10. MicroPort Scientific Corporation
11. OrbusNeich Medical Company Limited
12. Reva Medical, Inc.
13. Terumo Corporation
14. Translumina
15. Wego Healthcare (Shenzhen) Co., Ltd.